“We’re thrilled to accelerate our next phase of growth with a partner like Medtronic who shares our goal of simplifying diabetes management to make life easier for the customers we serve,” said Jesse J. Kim, CEO and founder of EOFlow. “Together, we’ll work to advance innovation in wearable insulin patch technology to expand our reach to more individuals around the world living with diabetes. With a global footprint in over 100 countries, ability to scale up manufacturing quickly, and advanced software and sensor capabilities, Medtronic is the ideal strategic partner for EOFlow.” 

“The acquisition of Somex Automation is a milestone for our company,” said Robbie Atkinson, CEO of Medical Manufacturing Technologies. “We are excited to bring a strong business with highly skilled employees into our family.”

“The acquisition reflects our investors’ commitment to the long-term growth and development of accūrō Solutions as the premiere service provider in the medical bill review industry,” said Chris Feeney, Executive Board Member of accūrō Solutions.

The transaction provides Abbott with a complementary solution for treating vascular disease. CSI’s leading atherectomy system prepares vessels for angioplasty or stenting to restore blood flow.

Gyrus Medical is located in Cardiff, Wales, United Kingdom, is also a device outsourcer, and will increase both ATL’s global footprint and capabilities.

Raymond W. Cohen, chief executive officer of Axonics. “We expect the Radian technology will improve patient comfort, increase physician confidence and SNM access, simplify the learning curve for physicians new to SNM, and increase PNE trial success rates, which should ultimately result in more adults being treated with our life-changing SNM therapy. We are confident that empowering physicians with innovative technology and tools has the potential to drive significant SNM market expansion in the years ahead.”